Related Experiment Video
Updated: Aug 14, 2025

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
Published on: January 17, 2025
Nuclear envelope morphology change upon repetitive treatment with modified antisense oligonucleotides targeting
Asmaa Abdelrahman1,2, Mette-Marie Wendelboe Nielsen1,3, Mette Halkjær Stage1,4
1Department of Green Technology, Faculty of Engineering, University of Southern Denmark, Odense, Denmark.
Abstract:
We present the influence of treating progeroid fibroblasts with two modified antisense oligonucleotides (ONs) on the nuclear envelope. Two modified ONs were designed to block ribosome binding during translation and spliceosome binding at the cryptic splice site. We analysed the changes in the nuclear morphology of progeria cell nuclei after repetitive transfection with modified ONs as a physical analysis tool for estimating alteration of the gene expression at the protein level. Confocal microscopy was used to image the nuclei, and the nuclear lobulations were quantified to study the changes in the morphology of the nuclear envelope upon treatment. PCR was used to identify the changes in the expression of lamin A and progerin after antisense treatment at the RNA level. We found a significant decrease in the number of nuclear envelope lobulations and a lower progerin expression in progeria cells after transfection with modified ONs.
Insights
Modified antisense oligonucleotides (ONs) targeting translation and splicing reduced nuclear envelope abnormalities and progerin expression in progeria cells. This offers a potential therapeutic strategy for Hutchinson-Gilford progeria syndrome.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Hutchinson-Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by premature aging.
- Nuclear envelope abnormalities, including lobulations, are a hallmark of progeria.
- Progerin, an aberrant protein, accumulates and contributes to cellular dysfunction in HGPS.
Purpose of the Study:
- To investigate the therapeutic potential of modified antisense oligonucleotides (ONs) in progeroid fibroblasts.
- To assess the impact of ONs on nuclear morphology and gene expression related to progeria.
Main Methods:
- Progeroid fibroblasts were treated with two modified antisense oligonucleotides designed to inhibit translation and spliceosome binding.
- Confocal microscopy was employed to visualize and quantify changes in nuclear envelope morphology.
- Polymerase chain reaction (PCR) was used to analyze RNA levels of lamin A and progerin.
Main Results:
- Treatment with modified ONs led to a significant reduction in nuclear envelope lobulations.
- Progerin expression was notably decreased in progeria cells following ONs transfection.
- Changes in nuclear morphology correlated with altered gene expression at both RNA and protein levels.
Conclusions:
- Modified antisense oligonucleotides demonstrate efficacy in ameliorating key cellular defects in progeria.
- These ONs represent a promising therapeutic avenue for addressing progerin accumulation and nuclear abnormalities in HGPS.
More Related Videos
Related Concept Videos
Regulation of Nuclear Protein Sorting
Nuclear Export of mRNA
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...

